Medpace Holdings

Medpace Holdings is a global full-service contract research organization (CRO) founded in 1992 in Cincinnati, Ohio. The company partners with pharmaceutical, biotechnology, and medical device sponsors to accelerate the development of safe and effective medical therapeutics across Phase I through Phase IV clinical trials. Medpace operates under a therapeutically focused model, providing integrated services including study start-up, clinical trial management, clinical monitoring, biostats and data management, regulatory affairs, medical writing, clinical safety, pharmacovigilance, and quality assurance. The company also operates comprehensive central and bioanalytical laboratories and core labs for cardiac safety and imaging. Medpace differentiates through deep therapeutic expertise across oncology, cardiovascular, immunology, neuroscience, rare diseases, and more than a dozen other specialty areas.